MedDataX Logo

State of Play of Non-tuberculous Mycobacteria in Alsace

NCT ID: NCT06185166

Last Updated: 2023-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-05

Study Completion Date

2024-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-tuberculous mycobacteriosis (NTM) are infectious diseases caused by mycobacteria that are not part of the Tuberculosis complex. More than 190 species have been identified to date.

As an environmental reservoir, it most often affects the lungs, skin and soft tissues, lymph nodes, but it can affect all organs. Varying in virulence depending on the species, most infections do not cause illness.

There is currently no coordinated care pathway for this pathology in Alsace. The means necessary to set up such a structure requires knowing the importance of the disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to determine the incidence of non-tuberculous mycobacterial infections in the ALSACE region, the proportion of cases in which the infection causes illness, and its evolution over time.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Tuberculous Mycobacteria

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Non-Tuberculous Mycobacteria

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult subject (≥ 18 years old)
* in whom a biological sample is culture positive for a non-tuberculous mycobacterium
* born in France and domiciled in Alsace (i.e. whose home postal code begins with 67 or 68)
* not opposing the reuse of its data for scientific research purposes

Exclusion Criteria

* Subject having expressed opposition to participating in the study
* not domiciled in Alsace
* Born abroad
* Isolation of a mycobacterium from the Tuberculosis complex and Mycobacterium gordonae
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de Pneumologie - CHU de Strasbourg - France

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Loïc KASSEGNE, MD

Role: CONTACT

Phone: 33 3 69 55 01 88

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Loïc KASSEGNE, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8780

Identifier Type: -

Identifier Source: org_study_id